vs
Side-by-side financial comparison of Stanley Black & Decker (SWK) and Stryker Corporation (SYK). Click either name above to swap in a different company.
Stryker Corporation is the larger business by last-quarter revenue ($7.2B vs $3.8B, roughly 1.9× Stanley Black & Decker). Stryker Corporation runs the higher net margin — 11.8% vs 1.4%, a 10.5% gap on every dollar of revenue. On growth, Stryker Corporation posted the faster year-over-year revenue change (11.4% vs 0.1%). Stryker Corporation produced more free cash flow last quarter ($1.9B vs $155.3M). Over the past eight quarters, Stryker Corporation's revenue compounded faster (16.9% CAGR vs 0.3%).
Stanley Black & Decker, Inc., formerly known as The Stanley Works, is an American manufacturer of industrial tools and household hardware, and a provider of security products. Headquartered in the Greater Hartford city of New Britain, Connecticut, Stanley Black & Decker is the result of the merger of The Stanley Works and Black & Decker on March 12, 2010.
The Stryker is a family of eight-wheeled armored fighting vehicles derived from the Canadian LAV III, which in turn derived from the Swiss Mowag Piranha. Stryker vehicles are produced by General Dynamics Land Systems-Canada (GDLS-C) for the United States Army in a plant in London, Ontario. It has four-wheel drive (8×4) and can be switched to all-wheel drive (8×8).
SWK vs SYK — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $3.8B | $7.2B |
| Net Profit | $51.4M | $849.0M |
| Gross Margin | 31.4% | 64.5% |
| Operating Margin | — | 25.2% |
| Net Margin | 1.4% | 11.8% |
| Revenue YoY | 0.1% | 11.4% |
| Net Profit YoY | -43.6% | 55.5% |
| EPS (diluted) | $0.34 | $2.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $7.2B | ||
| Q3 25 | $3.8B | $6.1B | ||
| Q2 25 | $3.9B | $6.0B | ||
| Q1 25 | $3.7B | $5.9B | ||
| Q4 24 | $3.7B | $6.4B | ||
| Q3 24 | $3.8B | $5.5B | ||
| Q2 24 | $4.0B | $5.4B | ||
| Q1 24 | $3.9B | $5.2B |
| Q4 25 | — | $849.0M | ||
| Q3 25 | $51.4M | $859.0M | ||
| Q2 25 | $101.9M | $884.0M | ||
| Q1 25 | $90.4M | $654.0M | ||
| Q4 24 | $194.9M | $546.0M | ||
| Q3 24 | $91.1M | $834.0M | ||
| Q2 24 | $-11.2M | $825.0M | ||
| Q1 24 | $19.5M | $788.0M |
| Q4 25 | — | 64.5% | ||
| Q3 25 | 31.4% | 63.6% | ||
| Q2 25 | 27.0% | 63.8% | ||
| Q1 25 | 29.9% | 63.8% | ||
| Q4 24 | 30.8% | 64.9% | ||
| Q3 24 | 29.9% | 64.0% | ||
| Q2 24 | 28.4% | 63.0% | ||
| Q1 24 | 28.6% | 63.6% |
| Q4 25 | — | 25.2% | ||
| Q3 25 | — | 18.7% | ||
| Q2 25 | — | 18.5% | ||
| Q1 25 | — | 14.3% | ||
| Q4 24 | 3.4% | 9.0% | ||
| Q3 24 | 10.6% | 19.7% | ||
| Q2 24 | 9.5% | 19.4% | ||
| Q1 24 | 8.3% | 18.5% |
| Q4 25 | — | 11.8% | ||
| Q3 25 | 1.4% | 14.2% | ||
| Q2 25 | 2.6% | 14.7% | ||
| Q1 25 | 2.4% | 11.1% | ||
| Q4 24 | 5.2% | 8.5% | ||
| Q3 24 | 2.4% | 15.2% | ||
| Q2 24 | -0.3% | 15.2% | ||
| Q1 24 | 0.5% | 15.0% |
| Q4 25 | — | $2.20 | ||
| Q3 25 | $0.34 | $2.22 | ||
| Q2 25 | $0.67 | $2.29 | ||
| Q1 25 | $0.60 | $1.69 | ||
| Q4 24 | $1.29 | $1.41 | ||
| Q3 24 | $0.60 | $2.16 | ||
| Q2 24 | $-0.07 | $2.14 | ||
| Q1 24 | $0.13 | $2.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $268.3M | $4.0B |
| Total DebtLower is stronger | $5.3B | — |
| Stockholders' EquityBook value | $9.0B | $22.4B |
| Total Assets | $21.8B | $47.8B |
| Debt / EquityLower = less leverage | 0.59× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $4.0B | ||
| Q3 25 | $268.3M | $3.3B | ||
| Q2 25 | $311.8M | $2.4B | ||
| Q1 25 | $344.8M | $2.3B | ||
| Q4 24 | $290.5M | $3.7B | ||
| Q3 24 | $298.7M | $3.9B | ||
| Q2 24 | $318.5M | $1.9B | ||
| Q1 24 | $476.6M | $2.3B |
| Q4 25 | — | — | ||
| Q3 25 | $5.3B | — | ||
| Q2 25 | $5.6B | — | ||
| Q1 25 | $5.6B | — | ||
| Q4 24 | $6.1B | — | ||
| Q3 24 | $6.1B | — | ||
| Q2 24 | $6.1B | — | ||
| Q1 24 | $6.1B | — |
| Q4 25 | — | $22.4B | ||
| Q3 25 | $9.0B | $21.8B | ||
| Q2 25 | $9.1B | $21.2B | ||
| Q1 25 | $8.8B | $20.9B | ||
| Q4 24 | $8.7B | $20.6B | ||
| Q3 24 | $8.9B | $20.1B | ||
| Q2 24 | $8.7B | $19.8B | ||
| Q1 24 | $8.9B | $19.2B |
| Q4 25 | — | $47.8B | ||
| Q3 25 | $21.8B | $47.1B | ||
| Q2 25 | $22.5B | $46.3B | ||
| Q1 25 | $22.5B | $46.0B | ||
| Q4 24 | $21.8B | $43.0B | ||
| Q3 24 | $22.5B | $43.8B | ||
| Q2 24 | $22.5B | $39.1B | ||
| Q1 24 | $23.9B | $39.4B |
| Q4 25 | — | — | ||
| Q3 25 | 0.59× | — | ||
| Q2 25 | 0.62× | — | ||
| Q1 25 | 0.63× | — | ||
| Q4 24 | 0.70× | — | ||
| Q3 24 | 0.69× | — | ||
| Q2 24 | 0.70× | — | ||
| Q1 24 | 0.69× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $221.2M | $2.1B |
| Free Cash FlowOCF − Capex | $155.3M | $1.9B |
| FCF MarginFCF / Revenue | 4.1% | 26.1% |
| Capex IntensityCapex / Revenue | 1.8% | 3.7% |
| Cash ConversionOCF / Net Profit | 4.30× | 2.52× |
| TTM Free Cash FlowTrailing 4 quarters | $369.6M | $4.3B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $2.1B | ||
| Q3 25 | $221.2M | $1.5B | ||
| Q2 25 | $214.3M | $1.1B | ||
| Q1 25 | $-420.0M | $250.0M | ||
| Q4 24 | $679.1M | $1.9B | ||
| Q3 24 | $285.8M | $1.5B | ||
| Q2 24 | $573.0M | $633.0M | ||
| Q1 24 | $-431.0M | $204.0M |
| Q4 25 | — | $1.9B | ||
| Q3 25 | $155.3M | $1.4B | ||
| Q2 25 | $134.7M | $928.0M | ||
| Q1 25 | $-485.0M | $127.0M | ||
| Q4 24 | $564.6M | $1.7B | ||
| Q3 24 | $199.3M | $1.3B | ||
| Q2 24 | $485.8M | $481.0M | ||
| Q1 24 | $-496.7M | $37.0M |
| Q4 25 | — | 26.1% | ||
| Q3 25 | 4.1% | 22.3% | ||
| Q2 25 | 3.4% | 15.4% | ||
| Q1 25 | -13.0% | 2.2% | ||
| Q4 24 | 15.2% | 25.9% | ||
| Q3 24 | 5.3% | 23.7% | ||
| Q2 24 | 12.1% | 8.9% | ||
| Q1 24 | -12.8% | 0.7% |
| Q4 25 | — | 3.7% | ||
| Q3 25 | 1.8% | 3.1% | ||
| Q2 25 | 2.0% | 3.0% | ||
| Q1 25 | 1.7% | 2.1% | ||
| Q4 24 | 3.1% | 4.1% | ||
| Q3 24 | 2.3% | 3.1% | ||
| Q2 24 | 2.2% | 2.8% | ||
| Q1 24 | 1.7% | 3.2% |
| Q4 25 | — | 2.52× | ||
| Q3 25 | 4.30× | 1.79× | ||
| Q2 25 | 2.10× | 1.26× | ||
| Q1 25 | -4.65× | 0.38× | ||
| Q4 24 | 3.48× | 3.54× | ||
| Q3 24 | 3.14× | 1.77× | ||
| Q2 24 | — | 0.77× | ||
| Q1 24 | -22.10× | 0.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SWK
| Tools And Outdoor Segment | $3.3B | 87% |
| Engineered Fastening Segment | $500.5M | 13% |
SYK
| Medical | $1.3B | 18% |
| Endoscopy | $1.1B | 16% |
| Traumaand Extremities | $1.1B | 15% |
| Instruments | $925.0M | 13% |
| Knees | $749.0M | 10% |
| Neuro Cranial | $669.0M | 9% |
| Neurovascular | $539.0M | 8% |
| Hips | $499.0M | 7% |
| Other Orthopaedics | $267.0M | 4% |
| Spine | $8.0M | 0% |